Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences
September 06 2017 - 8:30AM
Business Wire
Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced that
the company will present corporate updates at three upcoming
investor conferences in New York City during September:
Rodman & Renshaw 19th Annual Global Investment Conference on
Monday, September 11, 2017 at 9:35 a.m. Eastern Time.
Cantor Fitzgerald Global Healthcare Conference on Monday,
September 25, 2017 at 10:20 a.m. Eastern Time.
Ladenburg Thalmann 2017 Healthcare Conference on Tuesday,
September 26, 2017 at 10:30 a.m. Eastern Time.
A live webcast of the presentations will be accessible through
the Investor Relations section of the company’s website at
www.synergypharma.com. A replay of the webcast will be available on
Synergy’s website for 90 days following each conference.
About Synergy Pharmaceuticals Inc.
Synergy is a biopharmaceutical company focused on the
development and commercialization of novel gastrointestinal (GI)
therapies. The company has pioneered discovery, research and
development efforts on analogs of uroguanylin, a naturally
occurring and endogenous human GI peptide, for the treatment of GI
diseases and disorders. Synergy’s proprietary GI platform includes
one commercial product TRULANCE™ (plecanatide) and a second lead
product candidate, dolcanatide. For more information, please visit
www.synergypharma.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170906005517/en/
Synergy Pharmaceuticals Inc.Gem Hopkins, 212-584-7610VP,
Investor Relations and Corporate
Communicationsghopkins@synergypharma.com
Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)
Historical Stock Chart
From Sep 2023 to Sep 2024